Skip to main content
. Author manuscript; available in PMC: 2022 May 15.
Published in final edited form as: Cancer Res. 2021 Sep 21;81(22):5613–5624. doi: 10.1158/0008-5472.CAN-21-0736

Figure 3. Dose-dependent cell viability in U2932, SUDHL-2, and SUDHL-5 cells after treatment with Scr-γtcPNA-155, PNA-155 and γtcPNA-155 for 48 hours.

Figure 3.

Cell viability was performed using trypan blue-based assay (n=3 technical triplicate), data represented as mean ± (SEM), * represents the statistical analysis were performed relative to Scr-γtcPNA-155 and ◆ represent analysis performed relative to PNA-155. *p<0.05, **p<0.01, ***p<0.001 and ****p<0.0001, ◆ p<0.05, ◆◆ p<0.01, unpaired two-tailed t-test was used for statistical analysis. The experiment was repeated three times and in triplicate.